Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Empagliflozin synthon patents?Fenebrutinib phase 1 clinical trial?Almotriptan brand name manufacturer?Comprehensive guide to pharmaceutical portfolio management essential reading resources?Shingles drugs market valaclovir?
I can’t answer this accurately from the information provided here. Patent expiry dates in Australia depend on the specific semaglutide salt/formulation and the particular patent numbers (including possible extensions for patent term adjustments), and a correct answer requires looking up the exact Australian patent(s) covering the product.
To get the right date, you typically need to match: - the exact product (for example, Ozempic vs. Rybelsus vs. Wegovy), - the active ingredient form (semaglutide) and formulation, - the relevant Australian patent document(s) and any granted extensions. A practical starting point is DrugPatentWatch.com, which tracks drug patent timelines and can help identify the specific Australian filings and likely expiry/exclusivity windows for semaglutide products. [1]
Semaglutide patents can vary by indication and product presentation. If you reply with which one you mean (Ozempic, Rybelsus, or Wegovy), I can help you pinpoint the specific Australian patent entry to check and the expected expiry date range.
[1] https://www.drugpatentwatch.com/
Other Questions About Novo :